chr6-29941785-C-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The variant allele was found at a frequency of 0.13 in 151,232 control chromosomes in the GnomAD database, including 493 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 493 hom., cov: 35)

Consequence

HCG4P5
intragenic

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.724

Publications

4 publications found
Variant links:
Genes affected
HCG4P5 (HGNC:22925): (HLA complex group 4 pseudogene 5)
HLA-A (HGNC:4931): (major histocompatibility complex, class I, A) HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.168 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HCG4P5 n.29941785C>A intragenic_variant
LOC124901298XR_007059541.1 linkn.813+2996G>T intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HLA-AENST00000396634.5 linkc.-281-181C>A intron_variant Intron 1 of 9 6 ENSP00000379873.1 P04439-1
POLR1HASPENST00000849679.1 linkn.66-13239G>T intron_variant Intron 1 of 5
POLR1HASPENST00000849682.1 linkn.751-13239G>T intron_variant Intron 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.130
AC:
19584
AN:
151116
Hom.:
489
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.171
Gnomad AMI
AF:
0.102
Gnomad AMR
AF:
0.144
Gnomad ASJ
AF:
0.128
Gnomad EAS
AF:
0.122
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.0892
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.106
Gnomad OTH
AF:
0.145
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.130
AC:
19630
AN:
151232
Hom.:
493
Cov.:
35
AF XY:
0.130
AC XY:
9585
AN XY:
73928
show subpopulations
African (AFR)
AF:
0.171
AC:
7027
AN:
41010
American (AMR)
AF:
0.144
AC:
2184
AN:
15188
Ashkenazi Jewish (ASJ)
AF:
0.128
AC:
442
AN:
3454
East Asian (EAS)
AF:
0.122
AC:
630
AN:
5144
South Asian (SAS)
AF:
0.163
AC:
773
AN:
4750
European-Finnish (FIN)
AF:
0.0892
AC:
943
AN:
10568
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.106
AC:
7192
AN:
67814
Other (OTH)
AF:
0.144
AC:
302
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.426
Heterozygous variant carriers
0
602
1204
1806
2408
3010
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.115
Hom.:
49

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
2.2
DANN
Benign
0.41
PhyloP100
-0.72
PromoterAI
0.18
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9260102; hg19: chr6-29909562; API